Patient-Led Models for Scaling Access Across High and Low-Income Countries

  • Reaching underserved populations when traditional access mechanisms fail
  • Managing chronic treatment access for thousands of patients across diverse health systems
  • Coordinating pharma, clinicians, and patient organizations to reduce friction and delay
  • Embedding access strategy early to support long-term equity and sustainability